Claritev Corporation Class A Common Stock

Claritev Corporation Class A Common Stock

Aktie · US62548M2098 · CTEV (XNYS)
Übersicht
AI-gestützte Analyse
Fundamental-Analyse
Was die Zahlen wirklich bedeuten – bevor der Markt es weiß.
Jetzt analysieren
News Sentiment
Kaufchance oder Alarmsignal? Was die aktuellen Nachrichten wirklich bedeuten.
Jetzt analysieren
Kaufen / Halten / Verkaufen
Kaufen, Halten oder Verkaufen? Das AI-Urteil auf einen Blick.
Jetzt analysieren
Risiko-Bewertung
Risiken erkennen, bevor sie zum Problem werden.
Jetzt analysieren
Fair Value
Zu teuer, fair bewertet oder ein Schnäppchen?
Jetzt analysieren
Neuste KI Analysen zu Claritev Corporation Class A Common Stock
Analyst Grade Summary
gauge-img
Kaufen
Starker Kauf
Kaufen
Halten
Verkaufen
Starker Verkauf
0
3
1
0
0
Kein Kurs
29.04.2026 14:12
Aktuelle Kurse von Claritev Corporation Class A Common Stock
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNYS: NYSE
NYSE
CTEV
USD
29.04.2026 14:12
22,87 USD
-0,62 USD
-2,64 %
IEXG: IEX
IEX
CTEV
USD
29.04.2026 14:02
23,13 USD
-0,36 USD
-1,55 %
Free Float & Liquidität
Free Float 42,68 %
Shares Float 7,24 M
Ausstehende Aktien 16,97 M
Firmenprofil zu Claritev Corporation Class A Common Stock Aktie
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.

Unternehmensdaten

Name Claritev Corporation Class A Common Stock
Firma Claritev Corporation
Symbol CTEV
Website https://www.claritev.com
Heimatbörse XNYS NYSE
ISIN US62548M2098
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Healthcare Information Services
CEO Travis S. Dalton
Marktkapitalisierung 399 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 2,7 T
Adresse 115 Fifth Avenue, 10003 New York City
IPO Datum 2020-04-03

Aktien-Splits

Datum Split
23.09.2024 1:40

Kennungswechsel

Datum Von Zu
28.02.2025 MPLN CTEV
09.10.2020 CCXX MPLN

Ticker Symbole

Name Symbol
NYSE CTEV
Weitere Aktien
Investoren, die Claritev Corporation Class A Common Stock halten, haben auch folgende Aktien im Depot:
AM.HONDA FI. 24/31 MTN
AM.HONDA FI. 24/31 MTN Anleihe
Norddeutsche Landesbank -GZ- EO-IHS 23(28)
Norddeutsche Landesbank -GZ- EO-IHS 23(28) Unbekannt